Valuation
- Market cap
- 245,750,000
- Revenue TTM
- $655,850,000
- Net income TTM
- $-135,410,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -20.65%
- Debt to equity
- 1.64
Trading
- Volume
- 904,100
- Avg volume
- 548,144
- Day's range
- $0.62 – $0.75
- Shares out
- 372,349,000
- Stochastic %K
- 29%
- Beta
- 1.59
- Analysts
- Strong Sell
- Price target
- $1.86
Company profile
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edib...
Show more
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy's brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 312 929 0993
- Website
- https://www.crescolabs.com
- Address
- 600 W. Fulton Street, Suite 800,, Chicago, United States
Latest news
No headlines yet.